Intellia Therapeutics, Inc. (NTLA)
13.56
-0.29
(-2.09%)
USD |
NASDAQ |
May 07, 14:31
Intellia Therapeutics SG&A Expense (TTM) : 119.80M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | 121.94M |
| KalVista Pharmaceuticals, Inc. | 191.34M |
| Beam Therapeutics, Inc. | 113.82M |
| Novavax, Inc. | 109.39M |
| Tango Therapeutics, Inc. | 41.51M |